| NCT ID | NCT07663136 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indiana University |
| Condition | Healthy Adult |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,800 participants |
| Start Date | 2026-07-28 |
| Primary Completion | 2029-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,800 participants in total. It began in 2026-07-28 with a primary completion date of 2029-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment communication is most effective for completing a type 1diabetes home screening kit? Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch). Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.
Eligibility Criteria
Inclusion Criteria: * Participant must be in Indiana Biobank * Participant must be able to provide consent * Ages 1-99 including pregnant women Exclusion Criteria: * Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study * While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07663136 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 99 Years, studying Healthy Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07663136 currently recruiting?
Yes, NCT07663136 is actively recruiting participants. Contact the research team at findt1d@iu.edu for enrollment information.
Where is the NCT07663136 trial being conducted?
This trial is being conducted at Indianapolis, United States.
Who is sponsoring the NCT07663136 clinical trial?
NCT07663136 is sponsored by Indiana University. The trial plans to enroll 3,800 participants.